Private Advisor Group LLC Sells 27 Shares of Chemed Co. (NYSE:CHE)

Private Advisor Group LLC trimmed its stake in shares of Chemed Co. (NYSE:CHE) by 3.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 803 shares of the company’s stock after selling 27 shares during the quarter. Private Advisor Group LLC’s holdings in Chemed were worth $425,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in Chemed during the fourth quarter worth $2,540,000. Kestra Investment Management LLC boosted its position in Chemed by 6.2% during the fourth quarter. Kestra Investment Management LLC now owns 1,060 shares of the company’s stock worth $561,000 after purchasing an additional 62 shares during the period. Venturi Wealth Management LLC boosted its position in Chemed by 82.6% during the fourth quarter. Venturi Wealth Management LLC now owns 776 shares of the company’s stock worth $411,000 after purchasing an additional 351 shares during the period. CIBC Asset Management Inc boosted its position in Chemed by 5.1% during the fourth quarter. CIBC Asset Management Inc now owns 457 shares of the company’s stock worth $242,000 after purchasing an additional 22 shares during the period. Finally, AlphaCentric Advisors LLC bought a new position in Chemed during the fourth quarter worth $520,000. 95.85% of the stock is owned by institutional investors.

Insider Activity

In other news, VP Brian C. Judkins acquired 145 shares of the business’s stock in a transaction that occurred on Monday, December 30th. The stock was acquired at an average price of $519.50 per share, with a total value of $75,327.50. Following the completion of the transaction, the vice president now directly owns 1,678 shares of the company’s stock, valued at $871,721. This trade represents a 9.46 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 3.32% of the stock is currently owned by company insiders.

Chemed Stock Performance

Shares of Chemed stock opened at $588.93 on Tuesday. The firm has a 50-day moving average of $546.69 and a 200-day moving average of $563.35. The stock has a market cap of $8.86 billion, a PE ratio of 29.76, a PEG ratio of 2.15 and a beta of 0.48. Chemed Co. has a 52-week low of $512.12 and a 52-week high of $654.62.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Monday, February 24th will be given a $0.50 dividend. The ex-dividend date is Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.34%. Chemed’s payout ratio is presently 10.05%.

Analyst Upgrades and Downgrades

CHE has been the subject of a number of recent research reports. Royal Bank of Canada reduced their target price on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research report on Tuesday, November 5th. StockNews.com cut shares of Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, February 27th.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.